Molecular Oncology

The main interest of our laboratory is the study of molecular events underlying the oncogenic process, especially in colorectal, gastric and head-and-neck cancer. Gaining a deeper understanding of the molecular mechanisms responsible for the tumorigenic process is essential to improve the diagnosis and treatment of these patients. We are also interested in the identification of novel biomarkers capable of predicting therapy response, thus contributing to treatment personalization for colorectal cancer patients. Finally, we explore novel therapeutic options for microvillus inclusion disease (MVID), a rare life-threatening intestinal disease.